Literature DB >> 7903785

Management of non-insulin-dependent diabetes mellitus.

G Williams1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903785     DOI: 10.1016/s0140-6736(94)90822-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Metformin: clinical use in type 2 diabetes.

Authors:  Elizabeth Sanchez-Rangel; Silvio E Inzucchi
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

Review 2.  Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments.

Authors:  A J Scheen
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 3.  Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword?

Authors:  L Niskanen
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 4.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Authors:  L J Scott; C M Spencer
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Care of patients with non-insulin dependent diabetes and hypertension.

Authors:  D Fone
Journal:  Br J Gen Pract       Date:  1994-07       Impact factor: 5.386

6.  Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

Authors:  S Kumar; A J Boulton; H Beck-Nielsen; F Berthezene; M Muggeo; B Persson; G A Spinas; S Donoghue; S Lettis; P Stewart-Long
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

Review 7.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

Review 8.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

9.  Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).

Authors:  Y A Hosokawa; H Hosokawa; C Chen; J L Leahy
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 10.  Comparative tolerability profiles of oral antidiabetic agents.

Authors:  A J Krentz; R E Ferner; C J Bailey
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.